Full Text
Optimising market access of Cancer Drugs in Canada- a study of Economic reviews by the Pan-Canadian Oncology Drug review (PCODR) expert committee

Abstract

Authors

K.Q. Qu Y. Jiang A. Gauthier

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×